Make Your Case to Attend the Novel CNS Biomarkers Summit Europe

Attending the Novel CNS Biomarkers Summit Europe is an opportunity to stay ahead of the rapidly evolving CNS biomarker landscape, gain practical insights from industry leaders, and bring back actionable strategies to strengthen your organisation's biomarker and drug development programmes.

As the only European meeting dedicated exclusively to advancing fluid, imaging and digital biomarkers for CNS drug development, the Novel CNS Biomarkers Summit Europe brings together biomarker, translational medicine, neuroscience, precision medicine, bioanalytical, multi-omics and clinical development leaders working across Alzheimer's disease, Parkinson's disease, ALS, schizophrenia, epilepsy, MSA and other CNS indications.

If your work involves biomarker discovery, validation, translational medicine, neuroscience, bioanalytics, precision medicine, clinical development, data science or regulatory strategy, this meeting offers highly relevant insights that can directly support your team's objectives.

Why This Meeting Matters to Your Organisation

  • Accelerate Biomarker Validation & Qualification: Learn how leading biopharma organisations are discovering, validating and implementing biomarkers that improve patient stratification, demonstrate target engagement and strengthen clinical decision-making
  • Stay Ahead of Emerging Biomarker Technologies: Explore advances in blood-based biomarkers, α-synuclein seed amplification assays, toxic oligomer assays, digital cognitive assessments, EEG biomarkers and multimodal biomarker strategies that are shaping the future of CNS drug development
  • De-Risk CNS Drug Development: Gain practical insights into generating earlier efficacy signals, overcoming assay harmonisation challenges, producing regulatory-ready data and building scalable biomarker programmes that improve development decisions
  • Benchmark Your Strategy Against Industry Leaders: Hear directly from experts from organisations including Roche, Lundbeck, UCB, Saniona, Monument Therapeutics and NRG Therapeutics as they share real-world approaches to biomarker implementation across multiple CNS indications
  • Build Valuable Collaborations: Connect with biomarker, translational medicine and clinical development leaders actively seeking new technologies, capabilities and partnerships to accelerate CNS therapeutic development

Who You Will Meet?

The Novel CNS Biomarkers Summit Europe brings together a highly targeted audience of 60+ biomarker, translational, precision medicine, multi-omics, neuroscience and clinical development leaders from Europe's leading biopharma and biotech organisations.

Attendees include senior leaders responsible for:

Biomarker Discovery & Development | Clinical Biomarkers | Translational Medicine | Neuroscience | Precision Medicine | Multi-Omics | Bioanalytics | Clinical Development | Digital Biomarkers & Data Science | Drug Discovery & Early Development

Attending Companies Include

Making Approval Easy: Example Justification Email

Subject: Approval Request to Attend the Novel CNS Biomarkers Summit Europe

Dear [Manager Name],

I am writing to request approval to attend the Novel CNS Biomarkers Summit Europe, taking place 30th November - 2nd December 2026 in London, UK. This meeting is the only European meeting dedicated exclusively to advancing fluid, imaging and digital biomarkers for CNS drug development, bringing together leaders across biomarker research, translational medicine, neuroscience, precision medicine and clinical development.

This year's agenda is closely aligned with our work in [insert area of responsibility], particularly our efforts related to [current project, therapeutic area or strategic priority].

Several sessions focus on topics directly relevant to our team's objectives, including biomarker validation, blood-based biomarkers, imaging technologies, digital endpoints, patient stratification, target engagement and regulatory-ready biomarker development. These discussions would provide valuable insight into emerging best practices and innovative approaches being adopted across the CNS biomarker landscape.

By attending, I would be able to:

  • Gain insight into the latest advances in fluid, imaging and digital biomarkers for CNS drug development
  • Learn from biomarker, translational medicine and neuroscience leaders from organisations including Roche, UCB, Lundbeck, Servier, AltPep, Bial, NRG Therapeutics and Saniona
  • Benchmark our current biomarker strategy against peers tackling similar scientific and clinical development challenges
  • Explore practical approaches to biomarker discovery, validation and implementation across multiple CNS indications
  • Identify new technologies, solutions and potential collaborators relevant to our programmes
  • Participate in dedicated workshops focused on accelerating CNS biomarker discovery and validation

Specifically, I believe the knowledge gained could support our work on [insert programme, initiative or business objective].

Following the conference, I will ensure the value of attendance is shared across the team by:

  • Preparing a summary report of key takeaways
  • Sharing relevant presentations, insights and industry updates
  • Presenting recommendations applicable to our current research and development activities
  • Highlighting emerging biomarker technologies and industry trends
  • Identifying potential collaboration, partnership and vendor opportunities discussed during the event

The summit attracts a focused audience of biomarker, translational medicine and neuroscience leaders and features case studies spanning Alzheimer's disease, Parkinson's disease, ALS, epilepsy, schizophrenia, MSA and other CNS indications.

I am confident that the knowledge, connections and best practices gained from this event will support both my professional development and our team's objectives as we continue to advance [insert project or company goal].

Thank you for considering my request. I would be happy to discuss the event in more detail and explain how attendance could support our wider business goals.

Kind regards,

[Your Name]
[Job Title]

Need Help Building Your Case?

If you require additional information to support your approval request, we're happy to provide:

  • Agenda recommendations tailored to your team and role
  • Speaker and attendee insights
  • Audience demographics
  • Registration and pricing information
  • A personalised ROI discussion
Event Image - Novel CNS Biomarkers Summit Europe

Explore the Agenda

Discover the latest case studies and practical strategies shaping the future of CNS biomarker development from Lundbeck, Roche, UCB & more.

Event Image - Novel CNS Biomarkers Summit Europe

Partner With Us

Position your brand alongside Europe's leading biomarker innovators and connect with decision-makers actively seeking new technologies and partners.

Event Image - Novel CNS Biomarkers Summit Europe

Join Biopharma Experts

Exchange ideas with biomarker, translational medicine and clinical development leaders tackling the biggest challenges in neurodegenerative drug development.